13 Undervalued Dividend Aristocrats to Buy Now

Page 7 of 12

6. Medtronic plc (NYSE:MDT)

Forward P/E Ratio as of March 9: 14.97

Medtronic plc (NYSE:MDT) develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.

Medtronic plc (NYSE:MDT) declared a quarterly dividend of $0.71 per share on March 5. The dividend is payable on April 17 to shareholders of record at the close of business on March 27, 2026. Medtronic has increased its annual dividend for the last 48 years and maintains the status of a dividend aristocrat. The stock currently boasts an impressive annual dividend yield of 3.18%.

Medtronic plc (NYSE:MDT) reported better-than-expected results for its Q3 2026 last month, beating estimates in both earnings and revenue. Moreover, the company delivered 6% YoY organic revenue growth, ahead of guidance, demonstrating the strength of its portfolio. This is the highest revenue growth that Medtronic has achieved in ten quarters.

Medtronic plc (NYSE:MDT) aims to deliver organic revenue growth of approximately 5.5% for FY 2026. The company also maintained its adjusted EPS guidance in the range of $5.62 to $5.66 for the year.

Page 7 of 12